IL33 and obstructive sleep apnea syndrome: The association of both conditions might increase the severity of disease by rising the levels of salivary IL-6 [18] and IL-33 [20], changing the composition of biofilm microorganisms, particularly in patients with moderate or severe OSA [21,22].